# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and lowers the price target from $32 to $21.
JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $31 to $27.
Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $29 to $24.
UBS analyst Colin Langan maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $27 to $24.
Adient (NYSE:ADNT) reported quarterly sales of $3.716 billion which missed the analyst consensus estimate of $3.826 billion by ...
Adient (NYSE:ADNT) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.64 by 50 pe...